Evaluation of Bezlotoxumab in Prevention of Recurrent C. Difficile Infection: A multicenter Single-Arm Study in Office Infusion Centers

March 3, 2020

Presented on October 3, 2018

Richard L. Hengel, MD
Timothy E. Ritter, MD
Ramesh V. Nathan, MD, FIDSA
Lucinda J. Van Anglen, PharmD
Stephen W. Marcella
Kevin W. Garey, Pharm.D., M.S., FASHP

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.